Info

Headquartered in Dallas, Texas, Hybrigen, Inc. is a privately-held biotechnology Company that has developed and commercialized proprietary proteomic platform technologies that dramatically accelerate the precise identification and characterization of high-value drug targets. Using these technologies, Hybrigen succeeds at discovering drug targets that are not found with other genomic and proteomic systems.